[Evaluation of MYCN amplification in Iranian patients with neuroblastoma by conventional and real time PCR]

Behzad, Poopak; Mohammad, Arzanian; Parvaneh, Vosough; Atoosa, Gharib; Amir, Hamidieh; Mohammad, Ehsani; Masood, Parsania; Abolfazl, Yousefian; Mohammad, Jahangirpour; Kobra, Farahani

Behzad, Poopak; Mohammad, Arzanian; Parvaneh, Vosough; Atoosa, Gharib; Amir, Hamidieh; Mohammad, Ehsani; Masood, Parsania; Abolfazl, Yousefian; Mohammad, Jahangirpour; Kobra, Farahani.

Medical Sciences Journal of Islamic Azad University. 2011; 21 (3): 188-195

em Persa | IMEMR | ID: emr-194714

ABSTRACT

ABSTRACT

Background:

There is an international consensus that evaluation of MYCNamplification should be done in all cases of newly diagnosed neuroblastoma. MYCN is the most important prognostic factor for neuroblastoma and determines treatment strategy

Buscar no Google

Imprimir

XML

Índice: IMEMR (Mediterrâneo Oriental) Idioma: Persa Revista: Med. Sci. J. Islam. Azad Univ. Ano de publicação: 2011

Similares

MEDLINE

LILACS

LIS

Buscar no Google

Imprimir

XML

Índice: IMEMR (Mediterrâneo Oriental) Idioma: Persa Revista: Med. Sci. J. Islam. Azad Univ. Ano de publicação: 2011